Symbiosis appoints new Business Development Manager

Symbiosis Pharmaceutical Services, a leading small-scale contract manufacturer of novel injectable pharmaceuticals for use in clinical trials, is pleased to announce the arrival of a new Business Development Manager, Joanne Anderson.With her employment we are strengthening our sales and marketing function. She will become a key point of communication for existing and new clients.She will be responsible for securing target sales through… Read More

Top 3 Reasons Why We’re Different!

By combining over 60 years of industry experience and by asking clients what was important to them before we built our facility, we identified the following:Flexibility – we can adapt our operational processes and systems to fit our clients’ project, and not the other way around. In practice that includes our approach to how we design and efficiently deliver our technical documentation and how we utilize our… Read More

Symbiosis is celebrating…

This month Symbiosis is celebrating its 2nd anniversary.As you can see from the photos below, we’ve come a long way!After listening to our clients we have developed a business that is focused on their needs.We have transformed a building site into a world class sterile manufacturing facility, been granted our GMP license and expanded our team to 20.Most importantly we have developed… Read More

Another successful regulatory milestone achieved

Leading on from the receipt of our Investigational Medicinal Products (IMP-MA) manufacturing licence from the UK Government regulator, the MHRA, in early 2012, Symbiosis hosted its first full MHRA cGMP inspection in December 2012.Not surprisingly, we are delighted to share with you that the inspection was successfully concluded to the satisfaction of the MHRA.This is another significant achievement for Symbiosis and is… Read More

Symbiosis opens contract injectables plant for early phase

“Our objective is to actively and aggressively drive down the amount of highly valuable drug development time”, Colin Mackay, Founder and CEORead the full story here :http://www.outsourcing-pharma.com/Contract-Manufacturing/Symbiosis-opens-contract-injectables-plant-for-early-phase

Symbiosis launches multi-million pound sterile drug manufacturing capability in Scotland

Symbiosis Pharmaceutical Services Limited, an MHRA-approved sterile manufacturing facility based in Stirling, Scotland is an exciting, young company specializing in the small-scale manufacture of sterile pharmaceuticals for clinical trials (fill/finish). Symbiosis has successfully completed clinical trial manufacturing projects with clients from across Europe and Asia, including Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL) and Encap Drug Delivery. The UK Government regulator, the… Read More

Get In Touch.


By ticking the box and clicking “Submit” below, you consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Symbiosis Pharmaceutical Services believes may be of value to you, relevant to your work and tailored to your professional profile and interests. This may include promotional information on products, services and events provided or organised by Symbiosis Pharmaceutical Services. By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Symbiosis' processing of your personal data, including its transfer internationally and to third parties, in accordance with it's privacy policy.